PFE vs WFC: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
VS
Wells Fargo & Company · Financial Services
$81.52
+30.6% upside to fair value
Grade B
QuantHub Verdict
WFC has more upside to fair value
(+30.6%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
WFC |
| Current Price |
$26.91 |
$81.52 |
| Fair Value Estimate |
$35.00 |
$106.49 |
| Upside to Fair Value |
+30.1%
|
+30.6%
|
| Market Cap |
$153.0B |
$250.7B |
| Forward P/E |
9.5x
|
11.9x
|
| EV / EBITDA |
13.8x
|
16.7x
|
| Price / Sales |
2.4x
|
2.0x
|
| Price / FCF |
16.8x
|
-13.2x
|
| Revenue Growth YoY |
-1.6%
|
+7.3%
|
| Gross Margin |
70.3%
|
64.5%
|
| Operating Margin |
24.7%
|
20.5%
|
| Return on Equity |
9.0%
|
12.0%
|
| Dividend Yield |
6.4% |
0% |
| FCF Yield |
5.9%
|
—
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Wells Fargo & Company is a diversified financial services firm operating primarily in consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. The company benefits from a seasoned CEO with extensive industry experience and has made significant progress in regulatory compliance and operational efficiency, including lifting its asset cap in 2025.…
Accumulation Zones
| Metric |
PFE |
WFC |
| Zone Low |
$25.00 |
$79.87 |
| Zone High |
$29.00 |
$90.52 |
| In Buy Zone? |
Yes
|
Yes
|